´ëÇѽÅÀåÇÐȸ KSN(Korea Society of Nephrology) 2022 (2ÀÏÂ÷) : 2022-05-27±³À°ÀÏÀÚ : 2022-05-27
±³À°Àå¼Ò : ¼¿ï µå·¡°ï½ÃƼȣÅÚ
±³À°ÁÖÁ¦ :
KSN(Korea Society of Nephrology) 2022 (2ÀÏÂ÷)ÁÖÃÖ±â°ü : ´ëÇѽÅÀåÇÐȸ
´ã´çÀÚ : ´ëÇѽÅÀåÇÐȸ
¿¬¶ôó : 02-3486-8736
À̸ÞÀÏ :
ksn@ksn.or.kr ±³À°Á¾·ù : ³»°úÀÇ»çÇÐ
Âü¼®¿¹»óÀοø : 2000¸í
Èñ¸ÁÆòÁ¡ : 6Á¡
Áö¿ª :
¼¿ïƯº°½Ã±³À°½Ã°£ : 27 ½Ã°£ 49ºÐ
¼¼ºÎ¼ö°·á : 200,000¿ø
ºñ°í ¡áȸ¿ø: »çÀü(100,000)/ÇöÀå(150,000) ¡áºñȸ¿ø: »çÀü(150,000)/ ÇöÀå(200,000) ¡áFellow-in-training,Resident,Trainee,Student,Nurse,etc: »çÀü(50,000)/ ÇöÀå(35,000) *Medical Student: ¸éÁ¦
±¸ºÐ ¿ùÀÏ °ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 05-27 Room 1(5F) 08:30~09:00 Clinical Course of Acute Kidney Injury in Elderly Patients ¿À¼¼¿ø(°í·Á´ëÇб³¾È¾Ïº´¿ø)
±³À°½Ã°£ 05-27 Room 1(5F) 09:00~09:30 Acute Kidney Injury in Patients With COVID-19 ÀÓÁ¤ÈÆ(Ä¥°î°æºÏ´ëº´¿ø)
±³À°½Ã°£ 05-27 Room 1(5F) 09:30~10:00 Novel Anticancer Drugs and Antibiotics Associated With Acute Kidney Injury ¹ÚÀÎÈÖ(¾ÆÁÖ´ëÇб³º´¿ø)
±³À°½Ã°£ 05-27 Room 1(5F) 10:00~10:30 Clinical Informatics and Risk Prediction of Acute Kidney Injury Horng Ruey Chua(National University Health System)
±³À°½Ã°£ 05-27 Room 1(5F) 10:40~11:10 Organ on a Chip in Acute Kidney Injury ±è¼¼Áß(ºÐ´ç¼¿ï´ëÇб³º´¿ø)
±³À°½Ã°£ 05-27 Room 1(5F) 11:10~11:40 VISTA of Kidney Macrophage in Acute Kidney Injury Çѽ¼®(¼¿ï´ëº´¿ø)
±³À°½Ã°£ 05-27 Room 1(5F) 11:40~12:10 A New Paradigm for an Old Disease Benjamin So(Queen Mary Hospital, The University of Hong Kong)
±³À°½Ã°£ 05-27 Room 1(5F) 12:10~12:40 From Microscopic to Macroscopic View Pang Wing Fai(Prince of Wales Hospital, The Chinese University of Hong Kong)
±³À°½Ã°£ 05-27 Room 1(5F) 14:40~15:10 Human Leukocyte Antigen Matching & Eplet Load Ruth Sapir-Pichhazde(McGill University)
±³À°½Ã°£ 05-27 Room 1(5F) 15:10~15:40 Surveillance Biopsies in Kidney Transplantation David Rush(Health Sciences Centre, University of Manitoba)
±³À°½Ã°£ 05-27 Room 1(5F) 15:40~16:10 Digital Subtraction Angiography Monitoring & Treatment of Chronic Active Apical Beat Mediated Rejection Á¤º´ÇÏ(°¡Å縯ÀÇ´ë)
Åä·Ð 05-27 Room 1(5F) 16:10~16:40 Discussion ½Å±ÔÅÂ,¾çÀç¼®,Á¤º´ÇÏ(¾ÆÁÖ´ëÇб³º´¿ø,¼¼ºê¶õ½ºº´¿ø,°¡Å縯ÀÇ´ë)
±³À°½Ã°£ 05-27 Room 1(5F) 16:40~17:10 ³ëºê¸ÞŸÆĸ¶: ¸¸¼º ½ÅÀåÁúȯ Ä¡·áÁ¦(NovRD) Á¤È¸À±(Æ÷Ç×°ø°ú´ëÇб³)
±³À°½Ã°£ 05-27 Room 1(5F) 17:10~17:40 Difelikefalin, a Novel Therapeutic Agent for the Treatment of Chronic Kidney Disease-Associated Pruritus in Adults Patients Receiving Hemodialysis: Results From Kalm 1 and Kalm 2 Phase 3 Trials Warren Wen(Cara Therapeutics Inc)
±³À°½Ã°£ 05-27 Room 1(5F) 17:40~18:10 Clinical Development of Efpeglenatide ¹é½ÂÀç(Çѹ̾àÇ°)
±³À°½Ã°£ 05-27 Room 1(5F) 18:10~18:40 ¾ËÁ¨¿À°¡³ë ¹ÙÀÌ¿ÀÅ×Å©³î·ÎÁö: ½ÅÀå ¿À°¡¿ÀÀÌµå ±è¿ë±Õ(°¡Å縯´ëÇб³¼ººó¼¾Æ®º´¿ø)
±³À°½Ã°£ 05-27 Room 2(3F) 08:30~09:00 Glomerular Hyperfiltration and High Protein Nephropathy Kamyar Kalantar-Zadeh(University of California Irvine)
±³À°½Ã°£ 05-27 Room 2(3F) 09:00~09:30 The Association Between Gut Microbiota and Uremia of Chronic Kidney Disease ±è¸í±Ô(°í·Á´ëÇб³¾È¾Ïº´¿ø)
±³À°½Ã°£ 05-27 Room 2(3F) 09:30~10:00 Targeting Immune Cell Metabolism in Kidney Diseases Niels Olsen Saraiva Ĉamara(Federal University of Sao Paulo)
±³À°½Ã°£ 05-27 Room 2(3F) 10:00~10:30 Blood Pressure Variability in Chronic Kidney Disease ¼»óÇå(Àü³²´ëÇб³º´¿ø)
±³À°½Ã°£ 05-27 Room 2(3F) 10:40~11:10 Ketone Bodies: Back to a Place in the Sun Shinji Kume(Shiga University of Medical Science)
±³À°½Ã°£ 05-27 Room 2(3F) 11:10~11:40 New Insights on Diabetic Kidney Disease-Ketone Bodies ÀÌ¿ëÈ£(¿¬¼¼ÀÇ´ë)
±³À°½Ã°£ 05-27 Room 2(3F) 11:40~12:10 Single Cell RNA-Sequencing to Analyze the Role of Macrophage in Early Diabetic Kidney Disease John He(Icahn School of Medicine at Mount Sinai)
±³À°½Ã°£ 05-27 Room 2(3F) 12:10~12:40 Single Cell Transcriptome of the Diabetic Kidney Reveals Dynamic Reprogramming Underlying Podocyte Regeneration and Injury ¹®ÁÖ¿µ(°µ¿°æÈñ´ëº´¿ø)
±³À°½Ã°£ 05-27 Room 2(3F) 14:40~15:10 Conservative and Preservative Approaches for the Management of Chronic Kidney Disease; Novel Dietary and Uremia Treatment Approaches Connie Rhee(University of California Irvine)
±³À°½Ã°£ 05-27 Room 2(3F) 15:10~15:40 Real World Data and Evidence: The Japan Chronic Kidney Disease Database Yuichiro Yano(Shiga University of Medical Science)
±³À°½Ã°£ 05-27 Room 2(3F) 15:40~16:10 Socioeconomic Status: A Factor Need to Be Considered in Chronic Kidney Disease Management °ÀºÁ¤(ÀÌÈÀÇ´ë)
±³À°½Ã°£ 05-27 Room 2(3F) 16:10~16:40 Causality Between Risk Factors and Chronic Kidney Disease Inferred from Mendelian Randomization Analysis ±èµ¿±â(¼¿ï´ëº´¿ø)
±³À°½Ã°£ 05-27 Room 2(3F) 16:50~17:07 Á¶¿µÁ¦ À¯¹ß ±Þ¼º ½Å±â´É Àå¾Ö¿¡¼ NecroX ÀÇ ¿¹¹æÀû ¿ªÇÒ ±Ô¸í ÇÔ¿µ·Ï(Ãæ³²´ëÇб³º´¿ø)
±³À°½Ã°£ 05-27 Room 2(3F) 17:07~17:24 ½Å¼¼´¢°ü ¿À°¡³ëÀÌµå ±â¹Ý colistin ½Åµ¶¼º ¸ðµ¨ °³¹ß Á¤ÇýÀ±(Â÷ÀÇ´ë)
±³À°½Ã°£ 05-27 Room 2(3F) 17:24~17:41 ½ÅÀå Æ©ºí·ÎÀÌµå ±â¼úÀ» ÀÌ¿ëÇÑ À¯Àü¼º ¼¼´¢°ü Áúº´ ¸ðµ¨ °³¹ß ¿¬±¸ ±èÁöÇö(ºÐ´ç¼¿ï´ëÇб³º´¿ø)
±³À°½Ã°£ 05-27 Room 2(3F) 17:41~17:58 Prediction of Death in Dialysis Patients Using Artificial Intelligence ¾ÈÁ¤³²(ÇѸ²´ëÇб³¼º½Éº´¿ø)
±³À°½Ã°£ 05-27 Room 2(3F) 17:58~18:15 ¾ËÆ÷Æ® ÁõÈıº¿¡¼ T ¸²ÇÁ±¸ÀÇ ½ÅÀå ¼Õ»ó ±âÀü ±Ô¸í ¿ÀÅ·Å(Àü³²´ëÇб³º´¿ø)
±³À°½Ã°£ 05-27 Room 2(3F) 18:15~18:32 ¿À°¡³ëÀÌµå ½Ã½ºÅÛÀ» È°¿ëÇÑ À¯ÀüÀû °áÇÔ ¿¬°ü ÄáÆϺ´ ¹ß»ý ±âÀü ¿¬±¸ ÀÓ¼±¿ì(¼¿ï¼º¸ðº´¿ø)
±³À°½Ã°£ 05-27 Room 2(3F) 18:32~18:49 ½ÅÀåÀ̽ÄȯÀÚ¿¡¼ ´ç´¢º´ Ä¡·áÁ¦ÀÎ SGLT2 ¾ïÁ¦Á¦ÀÇ À̽Ľűâ´É ¹× »ç¸Á·ü °³¼± È¿°ú °ËÁõ ÀÓÁ¤ÈÆ(Ä¥°î°æºÏ´ëº´¿ø)
±³À°½Ã°£ 05-27 Room 3(3F) 08:30~09:00 Anemia and Chronic Kidney Disease-Mineral Bone Disorder Interaction Michele Eisenga(University of Groningen)
±³À°½Ã°£ 05-27 Room 3(3F) 09:00~09:30 Anemia and the Heart in Chronic Kidney Disease ÃÖÈÆ¿µ(°³²¼¼ºê¶õ½ºº´¿ø)
±³À°½Ã°£ 05-27 Room 3(3F) 09:30~10:00 scRNA Sequencing of the Kidney and the Heart Christoph Kuppe(RWTH Aachen University)
±³À°½Ã°£ 05-27 Room 3(3F) 10:00~10:30 Current Status of Exosomal Research and Its Clinical Implication in Kidney Disease ÀÌ»óÈ£(°µ¿°æÈñ´ëº´¿ø)
±³À°½Ã°£ 05-27 Room 3(3F) 10:40~11:10 Autophagy in Regulation of Aquaporins Weidong Wang(Sun Yat-sen University)
±³À°½Ã°£ 05-27 Room 3(3F) 11:10~11:40 Genetic Kidney Disease and Kidney Organoids ±è¿ë±Õ(°¡Å縯´ëÇб³¼ººó¼¾Æ®º´¿ø)
±³À°½Ã°£ 05-27 Room 3(3F) 11:40~12:10 Role of KLC3 of CILK1 Deficiency-Related Polycystic Kidney Disease ¹ÚÁ¾ÈÆ(¼÷¸íÀÇ´ë)
±³À°½Ã°£ 05-27 Room 3(3F) 12:10~12:40 ADAMTS9-Related Renal Disorders and Disease Modeling ÁöÇ念(¿¬¼¼ÀÇ´ë)
±³À°½Ã°£ 05-27 Room 3(3F) 16:50~17:15 Roles and Responsibilities of Nephrologists at Pre-transplant Period: Current State in Thailand Nuttasith Larpparisuth(Mahidol University)
±³À°½Ã°£ 05-27 Room 3(3F) 17:15~17:40 Management at the Transplant Event and Immediate Post-transplant Period: Current State in Taiwan Ming-Ju Wu(Taichung VGH)
±³À°½Ã°£ 05-27 Room 3(3F) 17:40~18:05 Management at the Long-Term Post-transplant Period: Current State in Japan Ken Sakai(Toho University)
±³À°½Ã°£ 05-27 Room 3(3F) 18:05~18:30 Safety and Follow-up of Living Donor ÀåÇý·Ã(¼º±Õ±ÇÀÇ´ë)
Åä·Ð 05-27 Room 3(3F) 18:30~18:50 Discussion ½ÅÈ£½Ä,Çѽ¿±,Á¤Á¾Ã¶(°í½Åº¹À½º´¿ø,°è¸íÀÇ´ë,ºÐ´ç¼¿ï´ëÇб³º´¿ø)
±³À°½Ã°£ 05-27 Room 4(3F) 08:30~09:00 Challenge on a National Research Foundation Project: Multi-Center, Randomized Controlled Trials in Nephrology ¹é¼±ÇÏ(ÇѸ²´ëÇб³µ¿Åº¼º½Éº´¿ø)
±³À°½Ã°£ 05-27 Room 4(3F) 09:00~09:30 Preparing for Nephrology Research Á¶ÀåÈñ(°æºÏ´ëº´¿ø)
±³À°½Ã°£ 05-27 Room 4(3F) 09:30~10:00 The Snowball Effect: From a Study to a Big Investigation ¹èÀºÈñ(Àü³²ÀÇ´ë)
±³À°½Ã°£ 05-27 Room 4(3F) 10:00~10:30 How to Set Up a Good Research Lab Á¶»ó°æ(°í·Á´ëÇб³¾È¾Ïº´¿ø)
±³À°½Ã°£ 05-27 Room 4(3F) 10:50~11:00 Quest of Biomarkers to Predict the Progression of Chronic Kidney Diseases in Children With Congenital Anomalies of the Kidneys and Urinary Tract of Korea; A Report From KNOW-Ped Chronic Kidney Disease ±èÁöÇö(ºÐ´ç¼¿ï´ëÇб³º´¿ø)
±³À°½Ã°£ 05-27 Room 4(3F) 11:00~11:10 Selective Application of Initial Steroid Regimen in Idiopathic Steroid-Sensitive Nephrotic Syndrome: The Preliminary Report of a Prospective-Multicenter Study ¹Ú¹ÎÁö(°æºÏ´ëº´¿ø)
±³À°½Ã°£ 05-27 Room 4(3F) 11:10~11:20 Impact of Obesity on Renal Function in the Elderly: Results From the Geriatric Cohort Database of the National Health Insurance Service, 2009~2015 ¹èÀºÁø(°æ»ó´ëÇб³Ã¢¿øº´¿ø)
±³À°½Ã°£ 05-27 Room 4(3F) 11:20~11:30 Is Neutrophil/Lymphocyte Ratio Associated With Glomerular Filtraton Rate and Proteinuria in Older Adults With Non-dialysis Chronic Kidney Disease? Aygul Celtik(School of Medicine, Ege University)
±³À°½Ã°£ 05-27 Room 4(3F) 11:30~11:40 Calorie Restriction Reprograms Single-Cell Transcriptional Landscape of Aging in Mouse Kidneys Á¤¼ö¿õ(°µ¿°æÈñ´ëº´¿ø)
±³À°½Ã°£ 05-27 Room 4(3F) 11:40~11:50 Air Pollution, Genetic Factors, and the Risk of Incident Chronic Kidney Disease: A Prospective Study of Polygenic Risk Score Analysis in the UK Biobank ÀÌÁ¤È¯(¼¿ïƯº°½Ãº¸¶ó¸Åº´¿ø)
±³À°½Ã°£ 05-27 Room 4(3F) 11:50~12:00 Effect of Metabolically Healthy Obesity on Cardiovascular Outcomes and Progression to End-Stage Renal Disease in Chronic Kidney Disease °½Å¿µ(°æÈñÀÇ´ë)
±³À°½Ã°£ 05-27 Room 4(3F) 12:00~12:10 Epigenetic Regulation: Does HDAC2 Plays Role in Drug Resistance via Regulation of P-gp and MRP-1 Rashmika Singh(sanjay gandhi post graduate institute of medical sciences)
±³À°½Ã°£ 05-27 Room 4(3F) 12:10~12:20 Ceria-Zirconia Nanoparticles Reduce Intracellular Globotriaosylceramide Accumulation and Attenuate Kidney Injury by Enhancing the Autophagy Flux in Cellular and Animal Models of Fabry Disease À±¼¼Èñ(°Ç¾çÀÇ´ë)
±³À°½Ã°£ 05-27 Room 4(3F) 12:20~12:30 Factors Associated With Severity of Polycystic Liver in the Patients With Autosomal Dominant Polycystic Kidney Disease: Results From Inherited Cystic Kidney Disease Genetic Cohort Study ¹ÚÇýÀÎ(°³²¼º½Éº´¿ø)
±³À°½Ã°£ 05-27 Room 4(3F) 12:30~12:40 Development of Crispr/cas9 Therapeutics Targeting A4GALT Using Patient Derived Kidney Organoids Model of Fabry Disease ÃÖ¼º(°¡Å縯ÀÇ´ë)
±³À°½Ã°£ 05-27 Room 4(3F) 14:50~15:00 Effect of Dual Inhibition of DPP4 and SGLT2 on Tacrolimus-Induced Diabetes Mellitus and Nephrotoxicity in Rat Model °íÀºÁ¤(¼¿ï¼º¸ðº´¿ø)
±³À°½Ã°£ 05-27 Room 4(3F) 15:00~15:10 Outcomes of ABO-Incompatible Living Donor Kidney Transplantation Compared to Waiting or Deceased Donor Kidney Transplantation ±¸Å¿¬(¼º³²½ÃÀÇ·á¿ø)
±³À°½Ã°£ 05-27 Room 4(3F) 15:10~15:20 Risk of New-Onset Atrial Fibrillation Among Heart, Kidney and Liver Transplant Recipients: Where Are We and Where Are We Going? Wei Syun Hu(CMUH)
±³À°½Ã°£ 05-27 Room 4(3F) 15:20~15:30 Anti-thymocyte Globulin Versus Basiliximab Induction for Kidney Transplantation in Elderly Patients: Matched Analysis With Korean Multicentric Registry ÀÌÁØ¿µ(¿øÁÖ¼¼ºê¶õ½ºº´¿ø)
±³À°½Ã°£ 05-27 Room 4(3F) 15:30~15:40 Prospective Study to Evaluate the Effectiveness of Donor-Derived Cell-Free DNA for Early Diagnosis of Acute Rejection in Renal Transplant Recipients ±èÇü´ö(¼¿ï¼º¸ðº´¿ø)
±³À°½Ã°£ 05-27 Room 4(3F) 15:40~15:50 Clinical Efficacy and Safety of Denosumab in Kidney Transplant Recipients With Osteoporosis ¹Ú¿ì¿µ(°è¸íÀÇ´ë ½ÅÀå³»°ú)
±³À°½Ã°£ 05-27 Room 4(3F) 15:50~16:00 Transition of Metabolic Dysfunction After Kidney Transplantation and Its Association With Transplant Outcomes: A Nationwide Prospective Cohort Study ÀÌÀ¯È£(ºÐ´çÂ÷º´¿ø)
±³À°½Ã°£ 05-27 Room 4(3F) 16:00~16:10 Combined Analysis of Human Leukocyte Antigen Class II Eplet Mismatch and Tacrolimus Levels for the Prediction of de Novo Donor Specific Antibody Development in Kidney Transplant Recipients ¹ÎÁö¿ø(¼¿ï¼º¸ðº´¿ø)
±³À°½Ã°£ 05-27 Room 4(3F) 16:10~16:20 Short-Term Predictive Models for Post-kidney Transplant Diabetes Mellitus Using Machine Learning Approach: Preliminary Data ÃÖ¼¿µ(¼¿ïÀÇ´ë)
±³À°½Ã°£ 05-27 Room 4(3F) 16:20~16:30 A Study of Clinical Presentation and Outcome of COVID 19 Infection in Kidney Transplant Recipients Manzoor Parry(Sher i kashmir institute of medical sciences)
±³À°½Ã°£ 05-27 Room 4(3F) 16:30~16:40 Clinical Trial of Allogeneic Mesenchymal Stem Cell Therapy for Chronic Active Antibody-Mediated Rejection in Kidney Transplant Recipients ±èÇü´ö(¼¿ï¼º¸ðº´¿ø)
±³À°½Ã°£ 05-27 Room 4(3F) 16:40~16:50 Current Status of Cytomegalovirus Prophylaxis and Its Clinical Impact in Kidney Transplant Recipients in Korea: The Korean Organ Transplantation Registry Study ±èÁø¼÷(°æÈñÀÇ´ë)